Biotech rally rests on fundamentals, M&A appetite, says ROTY's Faison
Source: SeekingAlpha
2026-07-09 04:33:52 ET
More on Health Care
- Soft Landing Myth: How This Week's Data Exposed The Hidden Recession
- Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
- AI Revolutionizing Biopharma: Faster, Better, Cheaper
- Healthcare breadth hits 15-year high, but XLV’s top holdings remain Quant Holds
- Weekly ETFs: Nine of 11 sectors record inflows; bitcoin leads outflows
Read the full article on Seeking Alpha
For further details see:
Biotech rally rests on fundamentals, M&A appetite, says ROTY's Faison
Nuvalent Inc.
NASDAQ: NUVL
NUVL Trading
0.02% G/L:
$123.965 Last:
796,738 Volume:
$123.97 Open:
NUVL Latest News
$7,421,901,467
39,959,611
0.31%
75
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
